These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7923557)

  • 21. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
    Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
    Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
    Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Pushkareva MY; Wannberg SL; Janoff AS; Mayhew E
    Cancer Immunol Immunother; 2000 Jan; 48(10):569-78. PubMed ID: 10630309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells.
    Heesbeen EC; Verdonck LF; Staal GE; Rijksen G
    Biochem Pharmacol; 1994 Apr; 47(9):1481-8. PubMed ID: 8185658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
    Principe P; Sidoti C; Braquet P
    Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
    Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha.
    Aroca JD; Sánchez-Piñera P; Corbalán-García S; Conesa-Zamora P; de Godos A; Gómez-Fernández JC
    Eur J Biochem; 2001 Dec; 268(24):6369-78. PubMed ID: 11737191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
    Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
    Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
    Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
    Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E
    Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X; Lu X; Arthur G
    Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
    Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
    Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
    Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
    Storch J; Munder PG
    Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
    Lohmeyer M; Workman P
    Br J Cancer; 1995 Aug; 72(2):277-86. PubMed ID: 7640206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ether lipids inhibit the effects of phorbol diester tumor promoters.
    Daniel LW; Etkin LA; Morrison BT; Parker J; Morris-Natschke S; Surles JR; Piantadosi C
    Lipids; 1987 Nov; 22(11):851-5. PubMed ID: 3444377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes.
    Vrablic AS; Albright CD; Craciunescu CN; Salganik RI; Zeisel SH
    FASEB J; 2001 Aug; 15(10):1739-44. PubMed ID: 11481221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Peters AC; Ahmad I; Janoff AS; Pushkareva MY; Mayhew E
    Lipids; 1997 Oct; 32(10):1045-54. PubMed ID: 9358430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antineoplastic properties of an ether glycerophosphonocholine, and analog of ET-18-OCH3-GPC.
    Salari H; Howard S; Bittman R
    Biochem Biophys Res Commun; 1992 Sep; 187(2):603-8. PubMed ID: 1530618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.